Now World View
76
โLife-changingโ drug for teenager who lost mother to genetic condition
The new drug called Lleniolisib (Joenja) is a simple tablet taken twice a day and is the first ever targeted treatment for activated PI3-Kinase delta syndrome (APDS), a rare inherited disorder.
Support the Now World View Media Group Buy Donating on the button below.
Discover more from Now World View
Subscribe to get the latest posts sent to your email.